Personalis - PSNL Stock Forecast, Price & News

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Personalis in the last twelve months. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PSNL shares.
View PSNL analyst ratings or view top-rated stocks.

7 brokers have issued 1-year price targets for Personalis' stock. Their PSNL share price forecasts range from $11.00 to $26.00. On average, they predict the company's stock price to reach $20.50 in the next year. This suggests a possible upside of 609.3% from the stock's current price.
View analysts price targets for PSNL or view top-rated stocks among Wall Street analysts.

Personalis' stock was trading at $14.27 on January 1st, 2022. Since then, PSNL stock has decreased by 79.7% and is now trading at $2.89.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our PSNL earnings forecast.

Personalis, Inc. (NASDAQ:PSNL) announced its quarterly earnings results on Wednesday, August, 3rd. The company reported ($0.60) earnings per share for the quarter, beating the consensus estimate of ($0.63) by $0.03. The business earned $18.24 million during the quarter, compared to analysts' expectations of $15.06 million. Personalis had a negative trailing twelve-month return on equity of 31.55% and a negative net margin of 122.53%.

Personalis updated its FY 2022 earnings guidance on Wednesday, August, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $62.00 million-$67.00 million, compared to the consensus revenue estimate of $64.54 million.

17 employees have rated Personalis Chief Executive Officer John West on Glassdoor.com. John West has an approval rating of 75% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Personalis investors own include Enphase Energy (ENPH), Pfizer (PFE), Dynavax Technologies (DVAX), QUALCOMM (QCOM), Advanced Micro Devices (AMD), NIO (NIO), NVIDIA (NVDA), Viking Therapeutics (VKTX), AbbVie (ABBV) and

(PSNL) raised $100 million in an IPO on Thursday, June 20th 2019. The company issued 6,700,000 shares at $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Cowen and Company served as the underwriters for the IPO and Oppenheimer was co-manager.

Personalis trades on the NASDAQ under the ticker symbol "PSNL."

Personalis' stock is owned by a number of retail and institutional investors. Top institutional shareholders include ARK Investment Management LLC (11.77%), JPMorgan Chase & Co. (8.41%), Nikko Asset Management Americas Inc. (2.11%), Sumitomo Mitsui Trust Holdings Inc. (2.11%), Wellington Shields Capital Management LLC (2.07%) and Wellington Shields & Co. LLC (2.02%). Insiders that own company stock include Aaron Tachibana, John Stephen West, Ken Ludlum, Lightspeed Venture Partners Se, Llp Abingworth, Richard Chen and Stephen Michael Moore.
View institutional ownership trends.

Shares of PSNL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PSNL stock can currently be purchased for approximately $2.89.

Personalis (NASDAQ:PSNL) has a market capitalization of $132.70 million and generates $85.49 million in revenue each year. The company earns $-65,230,000.00 in net income (profit) each year or ($2.08) on an earnings per share basis.

The company employs 325 workers across the globe.

Personalis' mailing address is 1330 O`BRIEN DRIVE, MENLO PARK CA, 94025. The official website for the company is www.personalis.com. The company can be reached via phone at (650) 752-1300 or via email at investors@personalis.com.